Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 582

1.

Exploratory analyses of the Danish Palliative Care Trial (DanPaCT): a randomized trial of early specialized palliative care plus standard care versus standard care in advanced cancer patients.

Johnsen AT, Petersen MA, Sjøgren P, Pedersen L, Neergaard MA, Damkier A, Gluud C, Fayers P, Lindschou J, Strömgren AS, Nielsen JB, Higginson IJ, Groenvold M.

Support Care Cancer. 2019 Aug 13. doi: 10.1007/s00520-019-05021-7. [Epub ahead of print]

PMID:
31410598
2.

Exercise-Based Rehabilitation for Heart Failure: Cochrane Systematic Review, Meta-Analysis, and Trial Sequential Analysis.

Taylor RS, Long L, Mordi IR, Madsen MT, Davies EJ, Dalal H, Rees K, Singh SJ, Gluud C, Zwisler AD.

JACC Heart Fail. 2019 Aug;7(8):691-705. doi: 10.1016/j.jchf.2019.04.023. Epub 2019 Jul 10.

3.

Total serum bile acids or serum bile acid profile, or both, for the diagnosis of intrahepatic cholestasis of pregnancy.

Manzotti C, Casazza G, Stimac T, Nikolova D, Gluud C.

Cochrane Database Syst Rev. 2019 Jul 5;7:CD012546. doi: 10.1002/14651858.CD012546.pub2. Review.

PMID:
31283001
4.

Quinolones for sepsis. A protocol for a systematic review of randomised clinical trials with meta-analysis and trial sequential analysis.

Korang SK, Maagaard M, Feinberg J, Perner A, Gluud C, Jakobsen JC.

Acta Anaesthesiol Scand. 2019 Sep;63(8):1113-1123. doi: 10.1111/aas.13418. Epub 2019 Jun 28. Review.

PMID:
31251397
5.

Plasma expanders for people with cirrhosis and large ascites treated with abdominal paracentesis.

Simonetti RG, Perricone G, Nikolova D, Bjelakovic G, Gluud C.

Cochrane Database Syst Rev. 2019 Jun 28;6:CD004039. doi: 10.1002/14651858.CD004039.pub2. Review.

PMID:
31251387
6.

Radix Sophorae flavescentis versus other drugs or herbs for chronic hepatitis B.

Liang N, Kong Z, Lu CL, Ma SS, Li YQ, Nikolova D, Jakobsen JC, Gluud C, Liu JP.

Cochrane Database Syst Rev. 2019 Jun 24;6:CD013106. doi: 10.1002/14651858.CD013106.pub2. Review.

PMID:
31232459
7.

Social skills training for attention deficit hyperactivity disorder (ADHD) in children aged 5 to 18 years.

Storebø OJ, Elmose Andersen M, Skoog M, Joost Hansen S, Simonsen E, Pedersen N, Tendal B, Callesen HE, Faltinsen E, Gluud C.

Cochrane Database Syst Rev. 2019 Jun 21;6:CD008223. doi: 10.1002/14651858.CD008223.pub3. Review.

PMID:
31222721
8.

Apparently conclusive meta-analyses on interventions in critical care may be inconclusive-a meta-epidemiological study.

Koster TM, Wetterslev J, Gluud C, Jakobsen JC, Kaufmann T, Eck RJ, Koster G, Hiemstra B, van der Horst ICC, Keus E.

J Clin Epidemiol. 2019 Jun 11;114:1-10. doi: 10.1016/j.jclinepi.2019.05.011. [Epub ahead of print] Review.

PMID:
31200004
9.

Power estimations for non-primary outcomes in randomised clinical trials.

Jakobsen JC, Ovesen C, Winkel P, Hilden J, Gluud C, Wetterslev J.

BMJ Open. 2019 Jun 6;9(6):e027092. doi: 10.1136/bmjopen-2018-027092.

10.

Glucocorticosteroids for people with alcoholic hepatitis.

Pavlov CS, Varganova DL, Casazza G, Tsochatzis E, Nikolova D, Gluud C.

Cochrane Database Syst Rev. 2019 Apr 9;4:CD001511. doi: 10.1002/14651858.CD001511.pub4.

11.

Circulating endostatin as a risk factor for cardiovascular events in patients with stable coronary heart disease: A CLARICOR trial sub-study.

Ruge T, Carlsson AC, Kjøller E, Hilden J, Kolmos HJ, Sajadieh A, Kastrup J, Jensen GB, Larsson A, Nowak C, Jakobsen JC, Winkel P, Gluud C, Ärnlöv J.

Atherosclerosis. 2019 May;284:202-208. doi: 10.1016/j.atherosclerosis.2019.02.031. Epub 2019 Mar 3.

PMID:
30959314
12.
13.

Assessing assumptions for statistical analyses in randomised clinical trials.

Nielsen EE, Nørskov AK, Lange T, Thabane L, Wetterslev J, Beyersmann J, de Uña-Álvarez J, Torri V, Billot L, Putter H, Winkel P, Gluud C, Jakobsen JC.

BMJ Evid Based Med. 2019 Apr 4. pii: bmjebm-2019-111174. doi: 10.1136/bmjebm-2019-111174. [Epub ahead of print]

PMID:
30948454
14.

Radix Sophorae flavescentis versus no intervention or placebo for chronic hepatitis B.

Liang N, Kong Z, Ma SS, Lu CL, Yang M, Feng LD, Shen C, Diao RH, Cui LJ, Lu XY, Nikolova D, Jakobsen JC, Gluud C, Liu JP.

Cochrane Database Syst Rev. 2019 Apr 3;4:CD013089. doi: 10.1002/14651858.CD013089.pub2.

PMID:
30941748
15.

Methodological advantages and disadvantages of parallel and crossover randomised clinical trials on methylphenidate for attention deficit hyperactivity disorder: a systematic review and meta-analyses.

Krogh HB, Storebø OJ, Faltinsen E, Todorovac A, Ydedahl-Jensen E, Magnusson FL, Holmskov M, Gerner T, Gluud C, Simonsen E.

BMJ Open. 2019 Mar 30;9(3):e026478. doi: 10.1136/bmjopen-2018-026478.

16.

Glucocorticosteroids for sepsis in children. A protocol for a systematic review.

Korang SK, Gluud C, Jakobsen JC.

Acta Anaesthesiol Scand. 2019 Jul;63(6):819-826. doi: 10.1111/aas.13358. Epub 2019 Mar 28. Review.

PMID:
30919946
17.

Error Matrix Tool to Overview the Validity of Evidence on Radix Sophorae flavescentis for Chronic Hepatitis B.

Liang N, Kong DZ, Ma SS, Lu CL, Yang M, Feng LD, Liu XH, Gluud C, Liu JP.

J Altern Complement Med. 2019 Mar 18. doi: 10.1089/acm.2018.0484. [Epub ahead of print]

PMID:
30883184
18.
19.
20.

Acetyl-L-carnitine for patients with hepatic encephalopathy.

Martí-Carvajal AJ, Gluud C, Arevalo-Rodriguez I, Martí-Amarista CE.

Cochrane Database Syst Rev. 2019 Jan 5;1:CD011451. doi: 10.1002/14651858.CD011451.pub2.

PMID:
30610762
21.

Updated 2018 NICE guideline on pharmacological treatments for people with ADHD: a critical look.

Faltinsen E, Zwi M, Castells X, Gluud C, Simonsen E, Storebø OJ.

BMJ Evid Based Med. 2019 Jun;24(3):99-102. doi: 10.1136/bmjebm-2018-111110. Epub 2018 Dec 10. No abstract available.

PMID:
30530806
22.

Dopamine in critically ill patients with cardiac dysfunction: A systematic review with meta-analysis and trial sequential analysis.

Hiemstra B, Koster G, Wetterslev J, Gluud C, Jakobsen JC, Scheeren TWL, Keus F, van der Horst ICC.

Acta Anaesthesiol Scand. 2019 Apr;63(4):424-437. doi: 10.1111/aas.13294. Epub 2018 Dec 4. Review.

23.

Early physical and psycho-educational rehabilitation in patients with coronary artery bypass grafting: A randomized controlled trial.

Højskov IE, Moons P, Egerod I, Olsen PS, Thygesen LC, Hansen NV, La Cour S, Bech KH, Borregaard B, Gluud C, Winkel P, Lindschou J, Kikkenborg Berg S.

J Rehabil Med. 2019 Feb 1;51(2):136-143. doi: 10.2340/16501977-2499.

24.

Viagra for fetal growth restriction: STRIDER Consortium replies to letter by Symonds and Budge.

Kenny LC, Alfirevic Z, Baker PN, Ganzevoort W, Gluud C, Groom KM, Jakobsen JC, Lim K, Magee LA, Papageorghiou AT, von Dadelszen P.

BMJ. 2018 Nov 22;363:k4872. doi: 10.1136/bmj.k4872. No abstract available.

PMID:
30467195
25.

Early mobilisation by head-up tilt with stepping versus standard care after severe traumatic brain injury - Protocol for a randomised clinical feasibility trial.

Riberholt CG, Lindschou J, Gluud C, Mehlsen J, Møller K.

Trials. 2018 Nov 8;19(1):612. doi: 10.1186/s13063-018-3004-x.

26.

Unbalanced risk-benefit analysis of ADHD drugs.

Faltinsen EG, Gluud C, Simonsen E, Zwi M, Storebø OJ.

Lancet Psychiatry. 2018 Nov;5(11):870. doi: 10.1016/S2215-0366(18)30334-1. Epub 2018 Oct 26. No abstract available.

PMID:
30401440
27.

Sexual rehabilitation for cardiac patients with erectile dysfunction: a randomised clinical trial.

Palm P, Zwisler AO, Svendsen JH, Thygesen LC, Giraldi A, Jensen KG, Lindschou J, Winkel P, Gluud C, Steinke E, Berg SK.

Heart. 2019 May;105(10):775-782. doi: 10.1136/heartjnl-2018-313778. Epub 2018 Oct 31.

PMID:
30381319
28.

Increased risks for random errors are common in outcomes graded as high certainty of evidence.

Gartlehner G, Nussbaumer-Streit B, Wagner G, Patel S, Swinson-Evans T, Dobrescu A, Gluud C.

J Clin Epidemiol. 2019 Feb;106:50-59. doi: 10.1016/j.jclinepi.2018.10.009. Epub 2018 Oct 19.

PMID:
30342970
30.

Letter to Editor: Response to AASLD Editorial/Message from the President.

Koretz RL, Jakobsen JC, Hauser G, Nikolova D, Gluud C.

Hepatology. 2019 May;69(5):2300. doi: 10.1002/hep.30298.

PMID:
30276829
31.

Cathepsin B and S as markers for cardiovascular risk and all-cause mortality in patients with stable coronary heart disease during 10 years: a CLARICOR trial sub-study.

Wuopio J, Hilden J, Bring C, Kastrup J, Sajadieh A, Jensen GB, Kjøller E, Kolmos HJ, Larsson A, Jakobsen JC, Winkel P, Gluud C, Carlsson AC, Ärnlöv J.

Atherosclerosis. 2018 Nov;278:97-102. doi: 10.1016/j.atherosclerosis.2018.09.006. Epub 2018 Sep 15.

PMID:
30261474
32.

Prognostic value of routinely available data in patients with stable coronary heart disease. A 10-year follow-up of patients sampled at random times during their disease course.

Winkel P, Jakobsen JC, Hilden J, Jensen G, Kjøller E, Sajadieh A, Kastrup J, Kolmos HJ, Larsson A, Ärnlöv J, Gluud C.

Open Heart. 2018 Sep 5;5(2):e000808. doi: 10.1136/openhrt-2018-000808. eCollection 2018.

33.

Letter to the editor re: Assessing the validity of surrogate endpoints in the context of a controversy about the measurement of effectiveness of hepatitis C virus treatment.

Koretz RL, Jakobsen JC, Gluud C.

BMJ Evid Based Med. 2018 Dec;23(6):240. doi: 10.1136/bmjebm-2018-111072. Epub 2018 Aug 31. No abstract available.

PMID:
30171020
34.

The STRIDER trials: ongoing research.

Ganzevoort W, Gluud C, Lim K, Mol B, Groom K.

Lancet Child Adolesc Health. 2018 Mar;2(3):e3. doi: 10.1016/S2352-4642(18)30036-1. Epub 2018 Feb 13. No abstract available.

PMID:
30169258
35.

Meta-Analysis and Trial Sequential Analysis Comparing Percutaneous Ventricular Assist Devices Versus Intra-Aortic Balloon Pump During High-Risk Percutaneous Coronary Intervention or Cardiogenic Shock.

Rios SA, Bravo CA, Weinreich M, Olmedo W, Villablanca P, Villela MA, Ramakrishna H, Hirji S, Robles OA, Mahato P, Gluud C, Bhatt DL, Jorde UP.

Am J Cardiol. 2018 Oct 15;122(8):1330-1338. doi: 10.1016/j.amjcard.2018.07.011. Epub 2018 Jul 24.

PMID:
30146099
36.

Why Cochrane should prioritise sharing data.

Shokraneh F, Adams CE, Clarke M, Amato L, Bastian H, Beller E, Brassey J, Buchbinder R, Davoli M, Del Mar C, Glasziou P, Gluud C, Heneghan C, Hoffmann T, Ioannidis JP, Jayaram M, Kwong J, Moher D, Ota E, Sheriff RS, Vale L, Goldacre B.

BMJ. 2018 Jul 30;362:k3229. doi: 10.1136/bmj.k3229. No abstract available. Erratum in: BMJ. 2018 Aug 15;362:k3542.

PMID:
30061322
37.

Assessing imprecision in Cochrane systematic reviews: a comparison of GRADE and Trial Sequential Analysis.

Castellini G, Bruschettini M, Gianola S, Gluud C, Moja L.

Syst Rev. 2018 Jul 28;7(1):110. doi: 10.1186/s13643-018-0770-1.

38.

The effect of metformin versus placebo in combination with insulin analogues on bone mineral density and trabecular bone score in patients with type 2 diabetes mellitus: a randomized placebo-controlled trial.

Nordklint AK, Almdal TP, Vestergaard P, Lundby-Christensen L, Boesgaard TW, Breum L, Gade-Rasmussen B, Sneppen SB, Gluud C, Hemmingsen B, Jensen T, Krarup T, Madsbad S, Mathiesen ER, Perrild H, Tarnow L, Thorsteinsson B, Vestergaard H, Lund SS, Eiken P.

Osteoporos Int. 2018 Nov;29(11):2517-2526. doi: 10.1007/s00198-018-4637-z. Epub 2018 Jul 19.

PMID:
30027438
39.

The Jury Is Still Out on the Benefits and Harms of Methylphenidate for Children and Adolescents With Attention-Deficit/Hyperactivity Disorder.

Storebø OJ, Faltinsen E, Zwi M, Simonsen E, Gluud C.

Clin Pharmacol Ther. 2018 Oct;104(4):606-609. doi: 10.1002/cpt.1149. Epub 2018 Jul 13.

PMID:
30006934
40.

β-Thalassemia heterozygote state detrimentally affects health expectation.

Graffeo L, Vitrano A, Scondotto S, Dardanoni G, Pollina Addario WS, Giambona A, Sacco M, Di Maggio R, Renda D, Taormina F, Triveri A, Attanasio M, Gluud C, Maggio A.

Eur J Intern Med. 2018 Aug;54:76-80. doi: 10.1016/j.ejim.2018.06.009. Epub 2018 Jun 19. Review.

PMID:
29934240
41.

No neurodevelopmental benefit of cerebral oximetry in the first randomised trial (SafeBoosC II) in preterm infants during the first days of life.

Plomgaard AM, Alderliesten T, van Bel F, Benders M, Claris O, Cordeiro M, Dempsey E, Fumagalli M, Gluud C, Hyttel-Sorensen S, Lemmers P, Pellicer A, Pichler G, Greisen G.

Acta Paediatr. 2019 Feb;108(2):275-281. doi: 10.1111/apa.14463. Epub 2018 Jul 5.

42.

Prevention of haematoma progression by tranexamic acid in intracerebral haemorrhage patients with and without spot sign on admission scan: a statistical analysis plan of a pre-specified sub-study of the TICH-2 trial.

Ovesen C, Jakobsen JC, Gluud C, Steiner T, Law Z, Flaherty K, Dineen RA, Bath PM, Sprigg N, Christensen H.

BMC Res Notes. 2018 Jun 13;11(1):379. doi: 10.1186/s13104-018-3481-8.

43.

Training, executive, attention and motor skills (TEAMS) training versus standard treatment for preschool children with attention deficit hyperactivity disorder: a randomised clinical trial.

Vibholm HA, Pedersen J, Faltinsen E, Marcussen MH, Gluud C, Storebø OJ.

BMC Res Notes. 2018 Jun 8;11(1):366. doi: 10.1186/s13104-018-3478-3.

44.

Systematic overview and critical appraisal of meta-analyses of interventions in intensive care medicine.

Koster TM, Wetterslev J, Gluud C, Keus F, van der Horst ICC.

Acta Anaesthesiol Scand. 2018 May 24. doi: 10.1111/aas.13147. [Epub ahead of print] Review.

PMID:
29797709
45.

Simple, low-cost group-counselling programme vs treatment as usual for patients with newly notified occupational hand eczema-Exploratory analyses of effects on knowledge, behaviour and personal resources of the randomized PREVEX clinical trial.

Fisker MH, Agner T, Sørensen JA, Vejlstrup SG, Lindschou J, Gluud C, Winkel P, Bonde JP, Ebbehøj NE.

Contact Dermatitis. 2018 Sep;79(3):127-135. doi: 10.1111/cod.13003. Epub 2018 May 17.

PMID:
29774562
46.

Cochrane Corner: drug-eluting stents versus bare-metal stents for acute coronary syndrome.

Feinberg J, Nielsen EE, Gluud C, Jakobsen JC.

Heart. 2018 Dec;104(23):1895-1897. doi: 10.1136/heartjnl-2017-312931. Epub 2018 May 14. No abstract available.

PMID:
29760240
47.

Do direct acting antivirals cure chronic hepatitis C?

Jakobsen JC, Nielsen EE, Koretz RL, Gluud C.

BMJ. 2018 May 10;361:k1382. doi: 10.1136/bmj.k1382. No abstract available.

PMID:
29748173
48.

Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - assessment of adverse events in non-randomised studies.

Storebø OJ, Pedersen N, Ramstad E, Kielsholm ML, Nielsen SS, Krogh HB, Moreira-Maia CR, Magnusson FL, Holmskov M, Gerner T, Skoog M, Rosendal S, Groth C, Gillies D, Buch Rasmussen K, Gauci D, Zwi M, Kirubakaran R, Håkonsen SJ, Aagaard L, Simonsen E, Gluud C.

Cochrane Database Syst Rev. 2018 May 9;5:CD012069. doi: 10.1002/14651858.CD012069.pub2. Review.

49.

Methodological concerns with network meta-analysis on drugs for attention deficit hyperactivity disorder.

Faltinsen EG, Storebø OJ, Gluud C.

Eur Child Adolesc Psychiatry. 2019 Jan;28(1):145-146. doi: 10.1007/s00787-018-1164-6. Epub 2018 May 9. No abstract available.

PMID:
29744668
50.

10-Year Associations Between Tumor Necrosis Factor Receptors 1 and 2 and Cardiovascular Events in Patients With Stable Coronary Heart Disease: A CLARICOR (Effect of Clarithromycin on Mortality and Morbidity in Patients With Ischemic Heart Disease) Trial Substudy.

Carlsson AC, Ruge T, Kjøller E, Hilden J, Kolmos HJ, Sajadieh A, Kastrup J, Jensen GB, Larsson A, Nowak C, Jakobsen JC, Winkel P, Gluud C, Ärnlöv J.

J Am Heart Assoc. 2018 Apr 23;7(9). pii: e008299. doi: 10.1161/JAHA.117.008299.

Supplemental Content

Support Center